Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Bjarnason, Georg A
  • Knox, Jennifer J
  • Kollmannsberger, Christian K
  • Soulieres, Denis
  • Ernst, D Scott
  • Zalewski, Pawel
  • Canil, Christina M
  • Winquist, Eric
  • Hotte, Sebastien
  • North, Scott A
  • Heng, Daniel Yick Chin
  • Macfarlane, Robyn Jane
  • Venner, Peter M
  • Kapoor, Anil
  • Hansen, Aaron Richard
  • Eigl, Bernhard J
  • Czaykowski, Piotr
  • Boyd, Ben
  • Wang, Lisa
  • Basappa, Naveen S

publication date

  • May 20, 2017